← Company directoryNASDAQ · SEC EDGAR
BioLife Solutions, Inc.
BLFSA primary-source company identity page built for fast discovery, filing verification and consistent financial research.
SHARE PRICE · INDICATIVE——
A recent price could not be verified. Check the exchange before trading.
ANALYSIS ROUTE
Four checks before any decision
Business model
Understand how the company earns and where demand originates.
Revenue and margin
Compare equivalent periods; separate growth from profitability.
Debt and cash flow
Test balance-sheet resilience and cash conversion.
Valuation and risk
Use sector peers, scenarios and explicit risk limits.
Company calendar
BioLife Solutions post-merger Nasdaq suspension
BioLife Solutions completed its merger with Repligen before the market opened on October 6. October 5 was the final trading day for BLFS, and Nasdaq suspension becomes effective October 7. Merger consideration is $11.25 in cash plus 0.1442 Repligen shares for each BLFS share held.
Nasdaq Trader ↗More NASDAQ records
Alphabetically adjacent directory records for faster navigation; this is not a peer or valuation classification.
BKYIBIO-key International, Inc.NASDAQ · SEC→BLBlackLine, Inc.NASDAQ · SEC→BLBDBlue Bird CorporationNASDAQ · SEC→BLDPBallard Power Systems, Inc. - Common SharesNASDAQ · SEC→BLINBridgeline Digital, Inc.NASDAQ · SEC→BLIVBeLive HoldingsNASDAQ · SEC→BLKBBlackbaud, Inc.NASDAQ · SEC→BLLNBillionToOne, Inc.NASDAQ · SEC→
DATA STATUS
Open official filings ↗Checking SEC financial statements
A dash means standardized data is unavailable. Always check the filing period, currency and accounting scope.